NCT02683200View on ClinicalTrials.gov

MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 3, 2015

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions
Adult Hepatocellular CarcinomaMetastatic Malignant Neoplasm in the Liver
Interventions
RADIATION

Image-Guided Adaptive Radiation Therapy

Undergo MRI-guided Tri-60Co teletherapy SBRT

RADIATION

Stereotactic Body Radiation Therapy

Undergo MRI-guided Tri-60Co teletherapy SBRT

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT02683200 - MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer | Biotech Hunter | Biotech Hunter